750PPhase Ib study of PF-04136309 (an oral CCR2 inhibitor)...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

750PPhase Ib study of PF-04136309 (an oral CCR2 inhibitor) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic adenocarcinoma

Noel, M., Lowery, M., Ryan, D., Wolpin, B., Bullock, A., Britten, C., Jin, B., Ganguly, B.J., Taylor, C.T., Yin, D., Wunderlich, D.A., Gamelin, E.C., Linehan, D.C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx369.132
Date:
September, 2017
File:
PDF, 52 KB
english, 2017
Conversion to is in progress
Conversion to is failed